These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9731897)

  • 1. Intracellular accumulation of thallium as a marker of cisplatin cytotoxicity in nonsmall cell lung carcinoma: an application of inductively coupled plasma mass spectrometry.
    Hanada T; Isobe H; Saito T; Ogura S; Takekawa H; Yamazaki K; Tokuchi Y; Kawakami Y
    Cancer; 1998 Sep; 83(5):930-5. PubMed ID: 9731897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T; Fujimura M; Kasahara K; Matsuda T
    Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP).
    Ohmori T; Nishio K; Ohta S; Kubota N; Adachi M; Komiya K; Saijo N
    Int J Cancer; 1994 Apr; 57(1):111-6. PubMed ID: 8150528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thromboxane receptor on the intracellular accumulation of cis-diamminedichloroplatinum(II) in non-small-cell but not in small-cell lung cancer cell lines.
    Bando T; Fujimura M; Kasahara K; Matsuda T
    Anticancer Res; 1998; 18(2A):1079-84. PubMed ID: 9615769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.
    Kasahara K; Fujimura M; Bando T; Shibata K; Shirasaki H; Matsuda T
    Br J Cancer; 1996 Nov; 74(10):1553-8. PubMed ID: 8932334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
    Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
    Koenuma M; Kasai H; Uchida N; Wada T; Hattori M; Oguma T; Totani T; Inaba M
    Anticancer Res; 1995; 15(2):417-21. PubMed ID: 7763015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and cytotoxicity of cisplatin-containing liposomes.
    Carvalho Júnior AD; Vieira FP; Melo VJ; Lopes MT; Silveira JN; Ramaldes GA; Garnier-Suillerot A; Pereira-Maia EC; Oliveira MC
    Braz J Med Biol Res; 2007 Aug; 40(8):1149-57. PubMed ID: 17665053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells.
    Mohammed Ael S; Eguchi H; Wada S; Koyama N; Shimizu M; Otani K; Ohtaki M; Tanimoto K; Hiyama K; Gaber MS; Nishiyama M
    Exp Lung Res; 2012 Nov; 38(9-10):463-74. PubMed ID: 23098063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
    Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
    Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attomole-per Cell Atomic Mass Spectrometry Measurement of Platinum and Gold Drugs in Cultured Lung Cancer Cells.
    Jakubczak W; Haczyk-Więcek M; Pawlak K
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of docetaxel and cisplatin for non-small cell lung cancer cell lines in vitro.
    Wang H
    Nagoya J Med Sci; 2000 Nov; 63(3-4):129-37. PubMed ID: 11201987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) .
    Kim HT; Kim DK; Cho YB; Kim TS; Jung I; Kim KH; Heo DS; Bang YJ; Shin SG; Kim NK
    Cancer Chemother Pharmacol; 1998; 41(2):109-16. PubMed ID: 9443623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Na+, K+-ATPase alpha1 subunit in the intracellular accumulation of cisplatin.
    Kishimoto S; Kawazoe Y; Ikeno M; Saitoh M; Nakano Y; Nishi Y; Fukushima S; Takeuchi Y
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):84-90. PubMed ID: 16044341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
    Heike Y; Takahashi M; Ohira T; Arioka H; Funayama Y; Nishio K; Ogasawara H; Saijo N
    Cancer Chemother Pharmacol; 1995; 35(3):200-4. PubMed ID: 7805177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.